Stallion India IPO Date, Review, Price and Key Information

Stallion India Fluorochemicals Limited IPO is a fully book-built issue, and the total IPO size is ₹199.45 crores. The issue is a combination of a fresh issue of 1.79 crore shares aggregating to ₹160.73 crores and an offer for sale of 0.43 crore shares aggregating to ₹38.72 crores.

The subscription period for the Stallion India Fluorochemicals Limited IPO started on January 16, 2025, and ended on January 20, 2025.

The allotment process was finalized on January 21, 2025. The Stallion India Fluorochemicals Limited IPO was listed on BSE and NSE on January 23, 2025.

The price band for the Stallion India Fluorochemicals Limited IPO is set at ₹90 per share.

Registrar for this IPO is Bigshare Services Private Limited, and the lead manager for Stallion India Fluorochemicals Limited IPO is Sarthi Capital Advisors Private Limited.

IPO Schedule

IPO Open Date	Thursday, 16 Jan, 2025
IPO Close Date	Monday, 20 Jan, 2025
IPO Allotment Date	Tuesday, 21 Jan, 2025
Refund Initiation	Wednesday, 22 Jan, 2025
Share credit in Demat	Wednesday, 22 Jan, 2025
Listing Date	Thursday, 23 Jan, 2025

Key Details

Price Band	₹90 Per Share
Lot Size	165 Shares
Face Value	₹10 Per Equity Share
Total Issue Size	₹199.45 Crores
Fresh Issue	₹160.73 Crores
OFS Issue	₹38.72 Crores
Issue Type	Fresh Issue & Offer for Sale
Listing At	BSE, NSE

Share Reservation

Investor Category	Shares Offered
QIB	50%
Retail	35%
NII/HNI	15%

About Stallion India Fluorochemicals Company

Stallion India Fluorochemicals Limited, established in 2002, specializes in refrigerants and industrial gases. Based in Mumbai, the company focuses on debulking, blending, and processing these gases, along with selling pre-filled cans and small cylinders.

With four strategically located facilities across India, Stallion adheres to stringent safety standards in storing and processing gases. Their products cater to diverse sectors, including air conditioning, fire fighting, semiconductor manufacturing, and pharmaceuticals.

Stallion primarily deals in fluorochemicals, classified as HCs, HFCs, and HFOs, which are widely used as refrigerants. Key products include R32, R152a, R410a and SF6. The company generated a revenue of ₹140.73 million during the period ended September 30, 2024, and a revenue of ₹233.23 million in fiscal year 2024.

The Indian fluorochemicals industry is experiencing steady growth driven by rapid industrialization. Government initiatives like the Production Linked Incentive (PLI) scheme and the Make in India initiative are also boosting domestic production and attracting investment in the sector.

Stallion India Fluorochemicals Financial Details

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	2356.90	2031.40	1261.79	980.07
Revenue	1407.32	2332.36	2255.04	1858.83
Profit After Tax	165.65	147.88	97.53	211.10
Net Worth	1345.32	1179.64	707.03	609.37
Reserves and Surplus	730.66	564.97	155.78	486.87
Total Borrowing	810.48	653.45	182.74	19.70

₹ In Crore

Key Performance Indicator

Basic EPS (in ₹)	Return on Net Worth (RoNW)	Net Asset Value (NAV)	Debt-Equity Ratio	Return on Equity (ROE)	Return on Capital Employed (ROCE)
2.54	12.54%	19.19	N/A	N/A	N/A

Offer Objectives

The document details the Offer Objects of the company, comprising a fresh issue and an offer for sale. The fresh issue involves up to 17,858,740 equity shares with a face value of ₹10 each, aggregating up to ₹[●] lakhs. Additionally, there is an offer for sale of 4,302,656 equity shares with a face value of ₹10 each, aggregating up to ₹[●] lakhs by the Promoter Selling Shareholder.

The Net Proceeds from the fresh issue will be utilized for:

Funding incremental working capital requirements of the Company.
Funding capital expenditure for the Semi-conductor & Specialty Gas debulking & blending facility (“Khalapur, Maharashtra”).
Funding capital expenditure for the Refrigerant debulking & blending facility (“Mambattu, Andhra Pradesh”).
General Corporate Purposes.

The estimated deployment for fiscal year 2026 includes ₹9,500 lakhs for working capital, ₹2,915.54 lakhs for the Khalapur facility, and ₹2,117.53 lakhs for the Mambattu facility. The Company confirms that there is no requirement to make firm arrangements of finance through verifiable means towards at least 75% of the stated means of finance, excluding the amount to be raised from the Fresh Issue and existing identifiable accruals.

The details of shareholding also specify the Promoter and Promoter Group holds 58,166,114 Equity Shares i.e. 94.63% and Public holds 3,300,400 Equity Shares i.e. 5.37%.